Description: Waverley Pharma Inc is a Canada-based company engaged in Biotechnology & Medical Research sector.The Company is focused on developing and commercializing Safe and Effective Small Molecules for Treatment of Cancer. Waverley Pharma is working in collaboration with a Indian conglomerate based in Mumbai to develop products for the treatment of cancer. Two of the lead products under developments are: WAV-101: WAV-101 is an injectable generic chemotherapy drug development for the treatment of non-small cell lung cancer and other indications; WAV-102 is also an injectable generic chemotherapy drug developed for the treatment of multiple myeloma and other indications. The Company has signed an agreement with Omgene Life Sciences for the development of another generic anti-cancer product WAV-103.
Home Page: www.waverleypharma.com
WAVE Technical Analysis
4-1250 Waverley Street
Winnipeg,
MB
R3T 6C6
Canada
Phone:
204 928 7907
Officers
| Name | Title |
|---|---|
| Mr. Larry Thiessen | Pres & CEO |
| Mr. Haaris Uddin B.Com., CPA | Chief Financial Officer |
Exchange: V
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3349 |
| Price-to-Sales TTM: | 1.0558 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |